Jove
Visualize
Contact Us

Related Experiment Videos

Bullous pemphigoid.

N Korman

    Journal of the American Academy of Dermatology
    |May 1, 1987
    PubMed
    Summary

    Bullous pemphigoid is an autoimmune skin disease causing blisters. Autoantibodies trigger inflammation, leading to subepidermal blisters, but it

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparative Effectiveness of Integrated Peer Support and Clinical Staffing Models for Community-Based Residential Mental Health Rehabilitation: A Prospective Observational Study.

    Community mental health journal·2022
    Same author

    Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post discharge.

    Epidemiology and psychiatric sciences·2020
    Same author

    An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia.

    Schizophrenia research·2018
    Same author

    Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2016
    Same author

    Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.

    The British journal of dermatology·2014
    Same author

    Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.

    The British journal of dermatology·2005
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Dermatology
    • Immunology
    • Pathology

    Background:

    • Bullous pemphigoid is an autoimmune blistering disease.
    • Characterized by tense bullae on normal or erythematous skin.
    • Histology shows subepidermal blisters with dermal inflammation.

    Purpose of the Study:

    • To discuss bullous pemphigoid.
    • To differentiate it from similar blistering diseases.
    • To explain its immunopathogenesis and treatment.

    Main Methods:

    • Review of clinical and histological features.
    • Discussion of immunologically mediated blistering diseases.
    • Explanation of autoantibody targets and inflammatory pathways.

    Main Results:

    • Bullous pemphigoid involves autoantibodies against basement membrane zone antigens.
    • Complement activation and inflammatory cell influx lead to tissue injury.
    • Subepidermal blister formation is the hallmark histologic finding.

    Conclusions:

    • Bullous pemphigoid is an autoimmune blistering disease with characteristic clinical and histological features.
    • It is differentiated from other blistering diseases like herpes gestationis and cicatricial pemphigoid.
    • Treatment typically involves systemic glucocorticosteroids and the condition is often self-limited.

    Related Experiment Videos